VRCA Verrica Pharmaceuticals Inc
2,084
$7.65
$0.34
(4.65%)
| Watchers | 2,084 |
| 52-Wk Low | $2.86 |
| 52-Wk High | $7.76 |
| Market Cap | $310.09M |
| Volume | 347,571.00 |
| 52-Wk High | $7.76 |
| 52-Wk Low | $2.86 |
Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare ConferenceGlobe Newswire • about 1 month ago
WEST CHESTER, Pa., April 02, 2024 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. ( Verrica ) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin diseases requiring...
Share to Feed
For the last three days, A.I.dvisor has detected that VRCA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
For the last three days, A.I.dvisor has detected that VRCA's AroonDown red line is above 70 while the AroonUp green line is below 30 for three straight days. This move could indicate a strong...
This is a signal that VRCA's price could be shifting from an uptrend to a downtrend. Traders may consider selling the stock or exploring put options...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This price move could be a signal that VRCA may fall back below the higher band and head toward the middle band. Traders may consider selling the stock, shorting the stock, or exploring put options...
We feel now is a pretty good time to analyse Verrica Pharmaceuticals Inc.'s ( NASDAQ:VRCA ) business as it appears the...
NCE status provides a minimum of five years of regulatory exclusivity The Company's U.S. patents and pending patent applications related to YCANTH are projected to expire between 2034 and 2041...
This indicator may be signaling that VRCA's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a Bullish indicator signaling VRCA's price could rise from here. Traders may explore going long the stock or buying call options...